Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Sook Ryun Park, Ji‐Youn Han et al.|Nature Cancer|2023Cited by 46
MHC II immunogenicity shapes the neoepitope landscape in human tumorsJeong Yeon Kim, Jung Kyoon Choi, Hongui Cha et al.|Nature Genetics|2023Cited by 37
Gene essentiality for tumour growth influences neoantigen‐directed immunoeditingHyoeun Bang, Kwoneel Kim, Jae Soon Park et al.|Clinical and Translational Medicine|2022Cited by 0